Dermatology
From the Journals
Secukinumab beat etanercept in 52-week psoriasis quality of life analysis
Secukinumab was associated with faster and greater improvements in self-reported quality of life in psoriasis patients, compared with etanercept...
From the Journals
Inpatient cost of atopic dermatitis called ‘substantial’
Financial burden and hospitalization prevalence of atopic dermatitis is rising in the U.S.
Conference Coverage
What’s old is new in topical psoriasis therapy
WAILEA, HAWAII – Fixed-combination halobetasol/tazarotene lotion proves safe and effective in phase II study.
Conference Coverage
Strontium, ketamine target troublesome itch
Topical formulations that contain ingredients such as ketamine and strontium have shown promise in alleviating severe itch in recent studies.
Conference Coverage
Omalizumab effects rapid, often complete, clearance of refractory bullous pemphigoid
ORLANDO – An anti-IgE antibody approved for asthma and chronic idiopathic urticaria may be a useful treatment for some patients with refractory...
Conference Coverage
Milk: Friend to bones, foe to faces?
Concerns about the role of dairy in acne still simmer.
News
Dupilumab: FDA approves first biologic for atopic dermatitis
Approved for moderate to severe atopic dermatitis in adults for whom topical prescription therapies don’t work or are not appropriate.
Conference Coverage
VIDEO: Looking at keloids from a different perspective
ORLANDO – It may be time to start considering new options for treating keloids, according to Amy McMichael, MD, professor of dermatology at Wake...
Conference Coverage
Novel antifungal had favorable safety, efficacy profile for onychomycosis in phase IIB study
ORLANDO – A new antifungal is set to move to phase III studies after meeting study endpoints with significant separation from controls, in...
From the Journals
Shingles vaccine deemed effective in people with autoimmune disease
Older adults with an autoimmune disease benefited for about 5 years before the vaccine’s effectiveness began to wane.
Conference Coverage
For Latinos, misperceptions and lack of medical care make preventing melanoma risky business
ORLANDO – Misperceptions about risk, inadequate health care are among the factors putting Latinos at greater risk for skin cancer.